This morning's announcement has seen the stock move up through previous 12 months high and short-term resistance with some gusto.
The sell side is looking very thin now. I think we could see a move up into the 70s (2010 highs)so long as there is nothing out of left field.
Positives for me:
* Sales tracking consistently in right direction
* Very strong board composition
* Healthcare/biotech sector the place to be over long-term
